France Glycobiology Market to Grow with a CAGR of 14.78% through 2028
According to
TechSci Research report, “France Glycobiology Market – By Region,
Competition, Forecast and Opportunities, 2028”, the France Glycobiology Market
stood at USD 89.12 million in 2022 and is anticipated to grow with a CAGR of 14.78%
in the forecast period, 2024-2028. This can be attributed to application in
therapeutics and disease biomarkers. Glycobiology is proving to be instrumental
in the development of therapeutics and identification of disease biomarkers.
The understanding of glycans' involvement in cell signaling, immune response,
and disease progression is opening avenues for targeted therapies.
Additionally, glycans are emerging as valuable biomarkers for various diseases,
including cancer and infectious diseases, driving the demand for glycobiology
applications in diagnostic and therapeutic settings.
Furthermore, the
development of glycoprotein therapeutics, including monoclonal antibodies and
other biologics, is a burgeoning trend in Glycobiology. Optimizing glycan
structures on therapeutic proteins can enhance their efficacy, stability, and
safety. This trend reflects a growing interest in leveraging glycobiological
knowledge for the design and improvement of therapeutic interventions in
France's healthcare sector.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"France Glycobiology Market”
The Glycobiology
market in France is experiencing steady growth driven by advancements in life
sciences and increasing research activities. Glycobiology, the study of
carbohydrates and their role in biological systems, has gained significant
attention in both academic and industrial sectors.
The France Glycobiology
Market is segmented into
product,
application, end user, regional distribution, and company.
Based on its application, Drug Discovery
is poised to emerge as a dominant application, catalyzing significant
advancements and innovation. The convergence of cutting-edge research and
technological breakthroughs in glycobiology has underscored its pivotal role in
drug development. With an increasing understanding of the intricate role
glycans play in various physiological processes, there is a growing emphasis on
leveraging this knowledge for targeted drug discovery. France, with its robust
research infrastructure and a burgeoning biotechnology sector, is strategically
positioned to capitalize on the potential of Glycobiology in pharmaceutical
applications. The synergy between academic research institutions, biotech
companies, and pharmaceutical giants creates a conducive environment for
collaborative efforts in unraveling the complexities of glycans and their
implications in diseases. As a result, Drug Discovery stands as a frontrunner,
driving the expansion of the Glycobiology Market in France, with the promise of
delivering innovative therapeutic solutions that address unmet medical needs.
Based on end
user, Research Institutes are poised to dominate as the primary end users in
the Glycobiology Market in France due to their pivotal role in advancing
scientific understanding and driving innovation in this field. Glycobiology,
with its complex study of carbohydrates and their biological roles, demands a
sophisticated research infrastructure, and research institutes play a central
role in conducting groundbreaking studies and experiments. The rich
collaboration between academia, government funding, and private partnerships
creates an environment conducive to pushing the boundaries of glycobiological
research. These institutes serve as hubs for interdisciplinary studies,
bringing together experts in biochemistry, molecular biology, and medicine to
unravel the intricacies of glycan structures and functions. Their focus on
basic and translational research positions them at the forefront of applying
glycobiological insights to address healthcare challenges, making research
institutes key players in shaping the trajectory of the Glycobiology Market in
France.
Major
companies operating in France Glycobiology Market are:
- Merck & Co., Inc.
- Agilent Technologies
France SASU
- THERMO FISHER SCIENTIFIC
FRANCE
- New England Biolabs
France
- Shimadzu France
- Takara Bio Europe
- Waters Corporation
- RayBiotech, Inc.
- Dextra Europe
- Bio-Rad Laboratories
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The
Glycobiology market in France is set to undergo a period of rapid evolution,
driven by the upcoming key trends. As technology, research methodologies, and
applications in Glycobiology continue to advance, the potential for
groundbreaking discoveries and transformative applications is immense.
Stakeholders in the Glycobiology market are poised to harness these trends to
shape the future of research, diagnostics, and therapeutics, placing France at
the forefront of innovation in Glycobiology,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“France Glycobiology Market By Product
(Enzymes, Instruments, Reagents, Kits), By Enzyme (Glycosidases &
Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate
Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others), By
Instruments (HPLC, Antibody arrays, Lectin arrays, MALDI-TOF, Mass
spectroscopy, Others), By Reagents (Monosaccharides, Glycoproteins,
Oligosaccharides, Others), By Kits (Glycan Releasing Kit, Glycan Labelling Kit,
Glycan Purification Kit, Others), By Application (Drug Discovery, Disease Diagnostics,
Virology, Cell Biology, Oncology, Others), By End User (Research Institutes,
Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical &
Biotechnology Companies, Others), By Region, By
Competition Forecast & Opportunities, 2018-2028F”,
has evaluated the future growth potential of France Glycobiology Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in France Glycobiology Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com